Closing the policy gap in diabetes care for individuals with advanced CKD
Authors' conclusion
This new model of care resulted in improved metabolic outcomes, increased utilisation of guideline-directed therapies, and enhanced access to diabetes technologies. However, the model also revealed significant unmet clinical needs in areas such as access to diabetes care, diabetes eye screening and foot surveillance.
Study context
- Population
- Individuals with diabetes and advanced CKD stages 4 or 5, or undergoing haemodialysis; mean age 68.5 (±13.0) years, 58.4% males
- Participants
- 291 individuals
- Exposure
- Pre- vs post-intervention of a new integrated diabetes kidney care model
- Outcome
- Metabolic outcomes in CKD not receiving dialysis
Methodological detailspre- and post-intervention comparison, renal satellite units
- Pre- and post-intervention comparison
- Renal satellite units
Main finding
As reported in the abstract
Difference
−13.0 mmol/mol
P < 0.001
HbA1c
Difference
−13.7 mm Hg
P < 0.0001
SBP
Difference
−2.9 kg
P < 0.0001
weight
Observational data: associations, not effects.
Further findings
Guideline-directed therapies and diabetes technology
- SGLT2i use
- 62.9%
- GLP1-RA use
- 28.4%
- Access to diabetes technology increased to
- 89%
Baseline characteristics
- Receiving ongoing diabetes care from secondary care diabetes specialist services
- 6%
- Nearly half had four or more long-term conditions; two-thirds had mild/severe frailty
Original publication
Closing the policy gap in diabetes care for individuals with advanced CKD. Diabet Med. Published 10 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →